Pfizer warns on arthritis drug Bextra NEW YORK, OCTOBER 15 : PFIZER Inc. on Friday said two clinical trials showed patients taking its anti-inflammatory drug Bextra, had a higher risk of cardio-vascular events during high-risk coronary bypass surgery.